Select your Country or Region

  • TargetMol | Compound LibraryArgentinaArgentina
  • TargetMol | Compound LibraryAustraliaAustralia
  • TargetMol | Compound LibraryAustriaAustria
  • TargetMol | Compound LibraryBelgiumBelgium
  • TargetMol | Compound LibraryBrazilBrazil
  • TargetMol | Compound LibraryBulgariaBulgaria
  • TargetMol | Compound LibraryCroatiaCroatia
  • TargetMol | Compound LibraryCyprusCyprus
  • TargetMol | Compound LibraryCzechCzech
  • TargetMol | Compound LibraryDenmarkDenmark
  • TargetMol | Compound LibraryEgyptEgypt
  • TargetMol | Compound LibraryEstoniaEstonia
  • TargetMol | Compound LibraryFinlandFinland
  • TargetMol | Compound LibraryFranceFrance
  • TargetMol | Compound LibraryGermanyGermany
  • TargetMol | Compound LibraryGreeceGreece
  • TargetMol | Compound LibraryHong KongHong Kong
  • TargetMol | Compound LibraryHungaryHungary
  • TargetMol | Compound LibraryIcelandIceland
  • TargetMol | Compound LibraryIndiaIndia
  • TargetMol | Compound LibraryIrelandIreland
  • TargetMol | Compound LibraryIsraelIsrael
  • TargetMol | Compound LibraryItalyItaly
  • TargetMol | Compound LibraryJapanJapan
  • TargetMol | Compound LibraryKoreaKorea
  • TargetMol | Compound LibraryLatviaLatvia
  • TargetMol | Compound LibraryLebanonLebanon
  • TargetMol | Compound LibraryMalaysiaMalaysia
  • TargetMol | Compound LibraryMaltaMalta
  • TargetMol | Compound LibraryMoroccoMorocco
  • TargetMol | Compound LibraryNetherlandsNetherlands
  • TargetMol | Compound LibraryNew ZealandNew Zealand
  • TargetMol | Compound LibraryNorwayNorway
  • TargetMol | Compound LibraryPolandPoland
  • TargetMol | Compound LibraryPortugalPortugal
  • TargetMol | Compound LibraryRomaniaRomania
  • TargetMol | Compound LibrarySingaporeSingapore
  • TargetMol | Compound LibrarySlovakiaSlovakia
  • TargetMol | Compound LibrarySloveniaSlovenia
  • TargetMol | Compound LibrarySpainSpain
  • TargetMol | Compound LibrarySwedenSweden
  • TargetMol | Compound LibrarySwitzerlandSwitzerland
  • TargetMol | Compound LibraryTaiwan,ChinaTaiwan,China
  • TargetMol | Compound LibraryThailandThailand
  • TargetMol | Compound LibraryTurkeyTurkey
  • TargetMol | Compound LibraryUnited KingdomUnited Kingdom
  • TargetMol | Compound LibraryUnited StatesUnited States
  • TargetMol | Compound LibraryOther CountriesOther Countries
Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Antibacterial
    (83)
  • Antifection
    (84)
  • Antifungal
    (48)
  • Antioxidant
    (60)
  • Apoptosis
    (111)
  • Autophagy
    (67)
  • COX
    (53)
  • Endogenous Metabolite
    (51)
  • NF-κB
    (56)
  • Others
    (903)
TargetMol | Tags By ResearchField
  • Anti-infective
    (1)
  • Cardiovascular disease
    (1)
  • Metabolic diseases
    (1)
  • Neurological disorders
    (2)
  • Other Fields
    (1)
Filter
Search Result
Results for "activities" in TargetMol Product Catalog
  • Inhibitor Products
    1783
    TargetMol | Activity
  • Natural Products
    879
    TargetMol | inventory
  • Recombinant Protein
    155
    TargetMol | natural
  • Peptides Products
    99
    TargetMol | composition
  • Isotope products
    15
    TargetMol | Activity
  • Compound Libraries
    12
    TargetMol | inventory
  • Inhibitory Antibodies
    10
    TargetMol | natural
  • Dye Reagents
    9
    TargetMol | composition
  • PROTAC Products
    8
    TargetMol | Activity
Natural Product Library
L6010
A unique collection of xnum natural products for high throughput screening (HTS) and high content screening (HCS);
  • $60,250
Backorder
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Ion Channel Inhibitor Library
L2300
A unique collection of xnum compounds targeting ion channels for research in ion channels-related diseases and ion channel drug discovery;
  • $13,530
Backorder
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Bioactive Compound Library
L4000
A collection of xnum small molecule compounds with validated activity for high throughput screening (HTS), high content screening (HCS), cell induction, and target identification;
  • $166,680
Backorder
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Human Endogenous Metabolite Library
L2500
A collection of xnum selected human endogenous metabolites for high throughput and high content screening.
  • $13,560
Backorder
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Alkaloid Natural Product Library
L6110
A unique collection of 500 natural alkaloids can be used for high throughput and high content screening;
  • $14,040
Backorder
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Clinical Compound Library
L3400
A unique collection of xnum compounds in clinical trial phases for high throughput screening (HTS) and high content screening (HCS);
  • $60,800
Backorder
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Anti-Alzheimer's Disease Compound Library
L9840
A unique collection of xnum compounds with anti-AD activities or acting on main drug targets of AD can be used for HTS and HCS.
  • $25,470
Backorder
Size
QTY
TargetMol | Citations Cited
Beta-Lactam Compound Library
L9820
A unique collection of xnum beta-lactam compounds, can be used in HTS and HCS;
  • $2,580
Backorder
Size
QTY
TargetMol | Citations Cited
Anti-Parkinson's Disease Compound Library
L9830
A unique collection of xnum compounds with anti-PD activities or acting on main drug targets of PD can be used for HTS and HCS.
  • $22,060
Backorder
Size
QTY
TargetMol | Citations Cited
Cyclic Peptide Library
L9610
xnum species of cyclic peptide molecules for high-throughput and high-content screening;
  • $3,930
Backorder
Size
QTY
TargetMol | Citations Cited
HIF-1 Signaling Pathway Compound Library
L8500
A unique collection of xnum HIF-1 related small chemicals can be used for drug discovery in ischemic disease and cancer and related mechanism studies;
  • $28,410
Backorder
Size
QTY
TargetMol | Citations Cited
Inhibitor Library
L2000
A unique collection of xnum inhibitors for research in cell signaling, high throughput screening (HTS) and high content screening (HCS) for new drugs;
  • $109,390
Backorder
Size
QTY
TargetMol | Citations Cited